Journal List > J Rheum Dis > v.21(6) > 1064150

Chung, Yoon, Choi, Song, Lee, and Yoo: A Case of Dermatomyositis Complicated with Pneumomediastinum Successfully treated with Cyclosporine A: a Case Report and Review of Literature

Abstract

Dermatomyositis (DM) is a systemic inflammatory disease affecting skeletal muscles and other organs. Spontaneous pneumomediastinum (PnM) has been previously reported as a rare complication of DM and it is known to occur more frequently in patients with interstitial lung disease (ILD). Here we report on a case of a 52-year-old woman with DM who developed spontaneous PnM, which was treated successfully with high-dose steroid pulse therapy and cyclosporine A (CsA). This case suggests that CsA can be an effective therapeutic agent in DM refractory to glucocorticoid therapy, with ILD or pulmonary fibrosis accompanied by DM. CsA should be considered as an initial immunosuppressive agent for patients with PnM in DM.

REFERENCES

1. Dickey BF, Myers AR. Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum. 1984; 14:60–76.
crossref
2. Kang EH, Lee EB, Shin KC, Im CH, Chung DH, Han SK, et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford). 2005; 44:1282–6.
crossref
3. Bradley JD. Spontaneous pneumomediastinum in adult dermatomyositis. Ann Rheum Dis. 1986; 45:780–2.
crossref
4. Kono H, Inokuma S, Nakayama H, Suzuki M. Pneumomediastinum in dermatomyositis: association with cutaneous vasculopathy. Ann Rheum Dis. 2000; 59:372–6.
crossref
5. Nagai Y, Ishikawa O, Miyachi Y. Pneumomediastinum and subcutaneous emphysema associated with fatal interstitial pneumonia in dermatomyositis. J Dermatol. 1997; 24:482–4.
crossref
6. Yamanishi Y, Maeda H, Konishi F, Hiyama K, Yamana S, Ishioka S, et al. Dermatomyositis associated with rapidly progressive fatal interstitial pneumonitis and pneumomediastinum. Scand J Rheumatol. 1999; 28:58–61.
7. Jansen TL, Barrera P, van Engelen BG, Cox N, Laan RF, van de Putte LB. Dermatomyositis with subclinical myositis and spontaneous pneumomediastinum with pneumothorax: case report and review of the literature. Clin Exp Rheumatol. 1998; 16:733–5.
8. Kim HJ, Hong YK, Yoo WH. Dermatomyositis, complicated with pneumomediastinum, successfully treated with cyclosporine A: a case report and review of literature. Rheumatol Int. 2009; 29:1101–4.
crossref
9. Park JH, Park SH, Kim PS, Lee JW, Yoo WH, Joo YS, et al. Fatal Pneumomediastinum and Subcutaneous Emphysema in a Patient with Dermatomyositis. J Korean Rheum Assoc. 1999; 6:287.
10. Song JS, Park YB, Lee JG, Kwon KH, Lee WK, Suh CH, et al. Two Cases of Spontaneous Pneumomediastinum in Dermatomyositis. J Korean Rheum Assoc. 1998; 5:152–7.
11. Park SH, Kum YS, Kim KC, Choe JY, Park SH, Kim SK. Pneumomediastinum and subcutaneous emphysema secondary to amyopathic dermatomyositis with crypto-genic organizing pneumonia in invasive breast cancer: a case report and review of literature. Rheumatol Int. 2009; 29:1231–5.
crossref
12. Masrouha KZ, Kanj N, Uthman I. Late-onset pneumomediastinum in dermatomyositis. Rheumatol Int. 2009; 30:291–2.
crossref
13. Lee MA, Hutchinson DG. Spontaneous pneumomediastinum secondary to refractory dermatomyositis successfully treated with rituximab. Clin Rheumatol. 2010; 29:945–6.
crossref
14. Kuroda T, Morikawa H, Satou T, Tanabe Y, Murakami S, Ito S, et al. A case of dermatomyositis complicated with pneumomediastinum successfully treated with cyclosporin A. Clin Rheumatol. 2003; 22:45–8.
crossref
15. Kim JJ, Kim D, Kim EK, Sohn IW, Jung KH, Choi CB, et al. Clinicial significance of spontaneous pneumomediastinum in dermatomyositis/polymyositis. J Korean Rheum Assoc. 2010; 17:143–52.
crossref
16. Oh JH, Ko JJ, Lee CK, Ko YH, Yun KS, Lim YS, et al. A case of spontaneous pneumomediastinum and subcutaneous emphysema in dermatomyositis: Including analysis of cases with dermatomyositis and pneumomediastinum in the literature. Korean J Med. 1998; 55:131–6.
17. Lee HY, Moon HI, Kang KY, Ju JH, Park SH, Kim HY. Two cases of Spontaneous pneumomediastinum in amyopathic dermatomyositis. Korean J Med. 2009; 77:479–83.

Figure 1.
Periungual erythema (A) and Gottron's sign (B).
jrd-21-317f1.tif
Figure 2.
Spontaneous pneumomediastinum (A) with subcutaneous emphysema (C) and resolved state (B and D) after the treatment with high dose steroid and cyclosporine.
jrd-21-317f2.tif
Table 1.
Review of dermatomyositis with spontaneous pneumomediastinum
No References Year Sex/Age Anti-Jo1 Ab ILD Skin lesion Management after PnM Outcome
1 Bradley et al. (3) 1986 M/42 NA NA Yes MPD+AZA Resolution
2 Kobayashi et al. (16) 1989 49/F NA Yes Yes High dose PDS+mediastinal drainage Death
3 Matsuda et al. (16) 1993 41/F NA Yes (−) Pulse MPD+PDS+AZA Death
4 Santos et al. (16) 1995 41/F NA Yes (−) PDS+AZA Death
5 Santiago et al. (11) 1998 M/10 (−) Yes NA Pulse MPD+HCQ Death
6 JH Park et al. (9) 1999 56/F (−) Yes Yes O2 therapy Death
7 HY Lee et al. (17) 2000 36/F (−) Yes Yes MPD+HCQ+cyclophosphamide Death
8 Kono et al. (4) 2000 M/30 (−) Yes Yes Pulse MPD+CsA Resolution
9 Kono et al. (4) 2000 M/25 NA Yes Yes Pulse MPD+CsA+AZA Death
10 Kono et al. (4) 2000 M/23 NA Yes Yes Pulse MPD Resolution
11 Kono et al. (4) 2000 F/59 NA Yes (−) Pulse MPD Resolution
12 Nonomura et al. (8) 2001 M/39 NA Yes NA CsA Resolution
13 Kuroda et al. (8) 2003 M/46 (−) Yes No PDS+CsA Resolution
14 Bin Yoo et al. (14) 2006 F/40 (−) Yes Yes MPD+IVIG+CsA Resolution
15 Terao et al. (8) 2007 M/16 (−) Yes Yes PDS+CsA Resolution
16 HY Lee et al. (17) 2007 45/F (−) Yes Yes Pulse MPD+cyclophosphamide Death
17 Powell et al. (11) 2007 M/34 (−) Yes NA Pulse MPD+IVIG Death
18 Park et al. (11) 2009 F/35 (−) Yes Yes PDS+AZA+cyclophosphamide Resolution
19 Yoo et al. (8) 2009 F/38 (−) Yes Yes MPD+CsA Resolution
20 Masrouha et al. (12) 2009 M/66 NA Yes NA Pulse MPD Resolution
21 Miyazaki et al. (11) 2011 M/29 (−) Yes NA Pulse MPD+CsA Resolution
22 Miyazaki et al. (11) 2011 F/41 (−) Yes NA Pulse MPD+CsA+cyclophosphamide+IVIG Resolution
23 Miyazaki et al. (11) 2011 F/43 (−) Yes NA Pulse MPD+CsA+cyclophosphamide Resolution
24 Hutchinson et al. (13) 2010 F/25 (−) Yes Yes Rituximab+MPD+cyclophosphamide Resolution
25 Kim et al. (15) 2010 F/59 (−) Yes (−) Pulse MPD+CsA Resolution
26 Kim et al. (15) 2010 F/51 (−) Yes (−) Pulse MPD+CsA Resolution
27 Kim et al. (15) 2010 F/42 (−) Yes (−) Pulse MPD+CsA Resolution
28 Kim et al. (15) 2010 F/43 (−) Yes (−) PDS+HCQ+IVIG+CsA Resolution
29 Kim et al. (15) 2010 F/44 (−) Yes (−) PDS+CsA Resolution
30 Kim et al. (15) 2010 F/54 (−) Yes (−) PDS+IVIG+Tacrolimus Resolution
31 Present case 2013 F/52 (−) Yes Yes Pulse MPD+CsA Resolution

AZA: azathiorpine, CsA: cyclosporin A, HCQ: hydroxychloroquine, IVIG: intravenous immunoglobulin, MPD: methylprednisone, PDS: prednisolone.

TOOLS
Similar articles